NATERA, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
NATERA, INC. (NTRA) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $205.49 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-03-15
- NATERA, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $51.97M, a 7.13% increase year-over-year.
- NATERA, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $55.33M, a 4.22% increase year-over-year.
- NATERA, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $52.28M, a 2.04% increase year-over-year.
- NATERA, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $45.91M, a 24.90% decline year-over-year.
- NATERA, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $205.49M, a 3.96% decline from fiscal 2016.
- NATERA, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $213.97M, a 13.71% increase from fiscal 2015.
- NATERA, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $188.17M, a 19.62% increase from fiscal 2014.
- NATERA, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $157.31M, a 186.25% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $51.97M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $107.30M derived: sum of 2 quarters · filed 2018-03-15 | $159.58M derived: sum of 3 quarters · filed 2018-03-15 | $205.49M 10-K · filed 2018-03-15 |
| 2017-09-30 | $55.33M 10-Q · filed 2017-11-09 | $107.61M derived: sum of 2 quarters · filed 2017-11-09 | $153.52M 10-Q · filed 2017-11-09 | $202.03M derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-06-30 | $52.28M 10-Q · filed 2017-08-09 | $98.19M 10-Q · filed 2017-08-09 | $146.70M derived: sum of 3 quarters · filed 2018-03-15 | $199.79M derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-03-31 | $45.91M 10-Q · filed 2017-05-10 | $94.42M derived: sum of 2 quarters · filed 2018-03-15 | $147.51M derived: sum of 3 quarters · filed 2018-03-15 | $198.75M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-12-31 | $48.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $101.60M derived: sum of 2 quarters · filed 2018-03-15 | $152.83M derived: sum of 3 quarters · filed 2018-03-15 | $213.97M 10-K · filed 2018-03-15 |
| 2016-09-30 | $53.09M 10-Q · filed 2017-11-09 | $104.32M derived: sum of 2 quarters · filed 2017-11-09 | $165.46M 10-Q · filed 2017-11-09 | $217.78M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $51.23M 10-Q · filed 2017-08-09 | $112.37M 10-Q · filed 2017-08-09 | $164.69M derived: sum of 3 quarters · filed 2018-03-15 | $209.12M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $61.14M 10-Q · filed 2017-05-10 | $113.46M derived: sum of 2 quarters · filed 2018-03-15 | $157.89M derived: sum of 3 quarters · filed 2018-03-15 | $202.41M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $52.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $96.75M derived: sum of 2 quarters · filed 2018-03-15 | $141.27M derived: sum of 3 quarters · filed 2018-03-15 | $188.17M 10-K · filed 2018-03-15 |
| 2015-09-30 | $44.42M 10-Q · filed 2016-11-14 | $88.94M derived: sum of 2 quarters · filed 2016-11-14 | $135.84M 10-Q · filed 2016-11-14 | $184.40M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $44.52M 10-Q · filed 2016-08-11 | $91.42M 10-Q · filed 2016-08-11 | $139.98M derived: sum of 3 quarters · filed 2017-03-16 | $185.78M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $46.90M 10-Q · filed 2016-05-13 | $95.46M derived: sum of 2 quarters · filed 2017-03-16 | $141.26M derived: sum of 3 quarters · filed 2017-03-16 | $177.00M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $48.56M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $94.36M derived: sum of 2 quarters · filed 2017-03-16 | $130.10M derived: sum of 3 quarters · filed 2017-03-16 | $157.31M 10-K · filed 2017-03-16 |
| 2014-09-30 | $45.80M 10-Q · filed 2015-11-13 | $81.54M derived: sum of 2 quarters · filed 2015-11-13 | $108.75M 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $35.74M 10-Q · filed 2015-08-13 | $62.95M 10-Q · filed 2015-08-13 | ||
| 2013-12-31 | $54.95M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |